Jazz Pharmaceuticals plc (NASDAQ: JAZZ) announced that its wholly-owned subsidiary, Jazz Investments I Limited, intends to offer $1.0 billion in ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE